Skip to content
value.today

Insight Pharmaceuticals Corp

Total raised
$71 M
2 rounds on record
Latest round
$65 M
Aug 2011
First round on record
Feb 2011
Today
Private
No later event on record

Funding rounds

2 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Insight Pharmaceuticals Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2011$65 MNo. 2$50 to $250 million

Insight Pharmaceuticals Corp: Raise no. 2, Aug 2011

Investors in this round

10 investors had bought by the notice of Aug 29, 2011: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$65 M of $65 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • C. Morris Stout · Executive Officer, Director
  • Daniel C. Reese · Executive Officer, Director
  • Dennis Kinsey · Executive Officer
  • Gary Downing · Executive Officer, Director
  • James Berwick · Executive Officer
  • Mark C. Poff · Executive Officer, Director
  • Kipp DeVeer · Director
  • Scott C. Emerson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Berwick, VP, Finance. Source: SEC Form D, newest notice filed Aug 29, 2011. Read the notice at the SEC.

equity, debtSEC
Feb 2011$6 MNo. 1$2 to $10 million

Insight Pharmaceuticals Corp: Raise no. 1, Feb 2011

Investors in this round

6 investors had bought by the notice of Mar 14, 2011: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • C. Morris Stout · Executive Officer, Director
  • Daniel C. Reese · Executive Officer, Director
  • Dennis Kinsey · Executive Officer
  • Gary Downing · Executive Officer, Director
  • James Berwick · Executive Officer
  • Mark C. Poff · Executive Officer, Director
  • Mickael Tukdarian · Executive Officer
  • Kipp C. DeVeer · Director
  • Michael C. Smith · Director
  • Michael C. Westhusing · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel C. Reese, Vice President. Source: SEC Form D, newest notice filed Mar 14, 2011. Read the notice at the SEC.

equitySEC
Jun 2009$32 MIssued in a merger or acquisition$10 to $50 million

Insight Pharmaceuticals Corp: Private sale, Jun 2009

Investors in this round

2 investors had bought by the notice of Jul 1, 2009: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $32 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • C. Morris Stout · Executive Officer, Director
  • Daniel C. Reese · Executive Officer, Director
  • Dennis Kinsey · Executive Officer
  • Joseph Suprenuk · Executive Officer
  • Mark Poff · Executive Officer, Director
  • Mickael Tukdarian · Executive Officer, Director
  • Craig Hille · Director
  • Robert Monk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “Proceeds from sale of securities wre contributed to Issuer's wholly-owned subsidiary for the sole purpose to acquire assets.”

Signed by Mickael Tukdarian, President. Source: SEC Form D, newest notice filed Jul 1, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Insight Pharmaceuticals Corp chose not to state its revenue in its newest notice of a funding round (Aug 2011).

    SEC Form D · Aug 2011

  • The industry group it chose in its notices: Other.

    SEC Form D · Aug 2011

That is all the official record says: Insight Pharmaceuticals Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Insight Pharmaceuticals Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Insight Pharmaceuticals Corp
NameRoleNamed in
C. Morris StoutExecutive officerAug 2011
Daniel C. ReeseExecutive officerAug 2011
Dennis KinseyExecutive officerAug 2011
Gary DowningExecutive officerAug 2011
James BerwickExecutive officerAug 2011
Mark C. PoffExecutive officerAug 2011
Mickael TukdarianExecutive officerMar 2011
Joseph SuprenukExecutive officerJul 2009
Mark PoffExecutive officerJul 2009
C. Morris StoutDirectorAug 2011
Daniel C. ReeseDirectorAug 2011
Gary DowningDirectorAug 2011
Kipp DeVeerDirectorAug 2011
Mark C. PoffDirectorAug 2011
Scott C. EmersonDirectorAug 2011
Kipp C. DeVeerDirectorMar 2011
Michael C. SmithDirectorMar 2011
Michael C. WesthusingDirectorMar 2011
Craig HilleDirectorJul 2009
Mark PoffDirectorJul 2009
Mickael TukdarianDirectorJul 2009
Robert MonkDirectorJul 2009